GFAP and depressive disorder: To investigate the contribution of exclusively adolescent-born neurons in the SGZ to depression-related circuitry, we have employed the GFAP-Tk mouse (Bush et al., 1998) and created a valgancyclovir (VGCV) treatment regimen that transiently reduced neurogenesis from P28-P42.